BI Asset Management Fondsmaeglerselskab A S cut its holdings in Exelon Co. (NASDAQ:EXC - Free Report) by 33.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,824 shares of the company's stock after selling 20,281 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S's holdings in Exelon were worth $1,499,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Millstone Evans Group LLC bought a new position in Exelon in the fourth quarter worth approximately $28,000. Stephens Consulting LLC lifted its holdings in shares of Exelon by 78.1% in the 4th quarter. Stephens Consulting LLC now owns 782 shares of the company's stock worth $29,000 after purchasing an additional 343 shares in the last quarter. Brown Lisle Cummings Inc. acquired a new position in Exelon during the fourth quarter worth $30,000. Crews Bank & Trust bought a new position in shares of Exelon in the fourth quarter valued at $34,000. Finally, Capital Advisors Ltd. LLC grew its holdings in shares of Exelon by 119.6% during the fourth quarter. Capital Advisors Ltd. LLC now owns 942 shares of the company's stock valued at $35,000 after buying an additional 513 shares during the last quarter. 80.92% of the stock is currently owned by institutional investors.
Exelon Stock Performance
EXC traded up $0.29 during trading on Monday, hitting $46.51. 981,070 shares of the company traded hands, compared to its average volume of 7,247,888. Exelon Co. has a one year low of $34.01 and a one year high of $48.11. The stock's fifty day moving average is $44.73 and its 200 day moving average is $41.05. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61. The firm has a market cap of $46.95 billion, a P/E ratio of 19.03, a price-to-earnings-growth ratio of 2.86 and a beta of 0.39.
Exelon (NASDAQ:EXC - Get Free Report) last released its earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share for the quarter, beating analysts' consensus estimates of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same quarter in the prior year, the company posted $0.60 earnings per share. As a group, equities analysts predict that Exelon Co. will post 2.64 EPS for the current fiscal year.
Exelon Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.44%. The ex-dividend date was Monday, February 24th. This is a boost from Exelon's previous quarterly dividend of $0.38. Exelon's dividend payout ratio is currently 65.31%.
Insider Transactions at Exelon
In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $40.57, for a total transaction of $59,353.91. Following the sale, the executive vice president now owns 2,271 shares in the company, valued at $92,134.47. This represents a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.10% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the stock. Barclays upped their target price on shares of Exelon from $42.00 to $48.00 and gave the stock an "overweight" rating in a report on Tuesday, February 25th. Guggenheim set a $47.00 target price on Exelon and gave the company a "buy" rating in a report on Tuesday, April 22nd. UBS Group upped their price target on Exelon from $45.00 to $47.00 and gave the stock a "neutral" rating in a report on Friday, March 21st. Scotiabank raised their price objective on Exelon from $42.00 to $44.00 and gave the company a "sector perform" rating in a research note on Thursday, February 13th. Finally, Morgan Stanley upped their target price on shares of Exelon from $46.00 to $48.00 and gave the stock an "equal weight" rating in a research note on Thursday, March 20th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Exelon presently has a consensus rating of "Hold" and an average price target of $45.78.
Check Out Our Latest Stock Report on Exelon
Exelon Company Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.